Research Progress on the Interaction Between Microorganisms and Macrophages and Their Role in the Mediation of the Onset and Development of Oral Cancer
Abstract
Oral squamous cell carcinoma is the sixth most common malignant tumor in the world, and the clinical treatment effect is not satisfactory. Because of the special nature of its location, oral cancer is inextricably linked with a wide variety of microorganisms, and its pathogenesis and development are also extremely susceptible to microbial regulation. In addition, the mediating role of the immune system is also indispensable to the course of tumor pathogenesis and development, especially tumor-associated macrophages, which amplify the regulatory role of microorganisms, and in turn regulate the microbial population components--two complementary effects that jointly exacerbate oral cancer. Herein, we summarized the existing research on the relationship between microorganisms and macrophages, as well as the regulatory role of microorganisms and macrophages in the pathogenesis and development of oral cancer. We also discussed the current status of and gaps in research on the relationship between microorganisms and macrophages and oral cancer. Both microorganisms and macrophages are considered promising indicators for prognosis, showing potentials to be used as new therapeutic targets. Despite some research interest in the role of microorganisms and macrophages in oral cancer, very few studies have linked them to oral precancerous lesions, and the mutual regulatory relationship between microorganisms and macrophages remains unclear. Therefore, in-depth exploration of the relationship network of microorganisms, macrophages and oral cancer is expected to provide more possibilities for the early diagnosis and treatment of tumors.
Keywords: Microorganisms, Tumor-associated macrophages, Tumor, Oral squamous cell carcinoma
Full Text:
PDFReferences
SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin，2021，71(3): 209–249. doi: 10. 3322/caac.21660.
Global cancer observatory: Cancer today. International Agency for Research (2021). [2022-09-19].https://gco.iarc.fr/today/fact-sheets-cancers.
SKLENICKA S， GARDINER S， DIERKS E J， et al. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome? J Oral Maxillofac Surg，2010，68(6): 1270–1275. doi: 10.1016/j.joms.2009.11.016.
PERERA M， Al-HEBSHI N N， PERERA I， et al. Inflammatory bacteriome and oral squamous cell carcinoma. J Dent Res，2018，97(6): 725–732. doi: 10.1177/0022034518767118.
KHATOON J， RAI R P， PRASAD K N. Role of Helicobacter pylori in gastric cancer: updates. World J Gastrointest Oncol，2016，8(2): 147–158. doi: 10.4251/wjgo.v8.i2.147.
DEWHIRST F E， CHEN T， IZARD J， et al. The human oral microbiome. J Bacteriol，2010，192(19): 5002–5017. doi: 10.1128/JB. 00542-10.
DEO P N， DESHMUKH R. Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol，2019，23(1): 122–128. doi: 10. 4103/jomfp.JOMFP_304_18.
YANG K， WANG Y， ZHANG S， et al. Oral microbiota analysis of tissue pairs and saliva samples from patients with oral squamous cell carcinoma--a pilot study. Front Microbiol，2021，12: 719601. doi: 10.3389/fmicb.2021. 719601.
KIM S Y， NAIR M G. Macrophages in wound healing: activation and plasticity. Immunol Cell Biol，2019，97(3): 258–267. doi: 10.1111/imcb. 12236.
AVILA-PONCE DE LEÓN U ， VÁZQUEZ-JIMÉNEZ A， MATADAMAS-GUZMAN M， et al. Transcriptional and microenvironmental landscape of macrophage transition in cancer: a boolean analysis. Front Immunol，2021，12: 642842. doi: 10.3389/fimmu. 2021.642842.
SARKAR P， MALIK S， LAHA S， et al. Dysbiosis of oral microbiota during oral squamous cell carcinoma development. Front Oncol，2021， 11: 614448. doi: 10.3389/fonc.2021.614448.
LI Z， CHEN G， WANG P， et al. Alterations of the oral microbiota profiles in chinese patient with oral cancer. Front Cell Infect Microbiol， 2021，11: 780067. doi: 10.3389/fcimb.2021.780067.
KOMLÓS G， CSURGAY K， HORVÁTH F， et al. Periodontitis as a risk for oral cancer: a case-control study. BMC Oral Health，2021，21(1): 640. doi: 10.1186/s12903-021-01998-y.
ZHANG L， LIU Y， ZHENG H J， et al. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol，2019，9: 476. doi: 10. 3389/fcimb.2019.00476.
GANLY I， YANG L， GIESE R A， et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer，2019，145(3): 775–784. doi: 10.1002/ijc.32152.
OLSEN I， YILMAZ Ö. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol，2019，11(1): 1563410. doi: 10.1080/ 20002297.2018.1563410.
WEN L， MU W， LU H， et al. Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment. J Dent Res，2020，99(6): 666–675. doi: 10.1177/0022034520909312.
LI Y， TAN X， ZHAO X， et al. Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis. Oral Oncol，2020，107: 104710. doi: 10.1016/j.oraloncology.2020.104710.
HARRANDAH A M， CHUKKAPALLI S S， BHATTACHARYYA I， et al. Fusobacteria modulate oral carcinogenesis and promote cancer progression. J Oral Microbiol，2020，13(1): 1849493. doi: 10.1080/ 20002297.2020.1849493.
BINDER GALLIMIDI A， FISCHMAN S， REVACH B， et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget，2015，6(26): 22613–22623. doi: 10.18632/oncotarget. 4209.
NEUZILLET C， MARCHAIS M， VACHER S， et al. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Sci Rep，2021，11(1): 7870. doi: 10.1038/s41598-021-86816-9.
NOSHO K， SUKAWA Y， ADACHI Y， et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol，2016，22(2): 557–566. doi: 10. 3748/wjg.v22.i2.557.
ZHANG S， LI C， LIU J， et al. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. FEBS J， 2020，287(18): 4032–4047. doi: 10.1111/febs.15233.
SHAO W， FUJIWARA N， MOURI Y， et al. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Sci Rep，2021，11(1): 14943. doi: 10.1038/s41598-021-94384-1.
INABA H， SUGITA H， KUBONIWA M， et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol，2014，16(1): 131–145. doi: 10.1111/cmi.12211.
KAMARAJAN P， ATEIA I， SHIN J M， et al. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLoS Pathog，2020，16(10): e1008881. doi: 10.1371/journal.
Refbacks
- There are currently no refbacks.
